Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $684M; returns 1 day -8.7%, 1 week -2.6%, 1 year -20.8%.

Olema Pharmaceuticals Inc. (OLMA) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and potential commercialization of novel targeted therapies for endocrine-driven cancers, with a primary focus on breast cancer. As a pre-revenue company, its business model is centered on advancing its pipeline through clinical trials towards regulatory approval.

Groups OLMA belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Oncology
• Breast Cancer Treatment
• Biopharmaceutical
• Pharmaceuticals
• Clinical Stage
• Endocrinology
• Cancer Therapeutics
• Life Sciences
• Fast Track Designation

OLMA financial model: income statement, cash flow and balance sheet